Jane Street’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-12,228
| Closed | -$82.9K | – | 12016 |
|
|
2026
Q1 | $82.9K | Sell |
12,228
-269
| -2% | -$2.1K | ﹤0.01% | 10729 |
|
|
2025
Q4 | $110K | Buy |
+12,497
| New | +$122K | ﹤0.01% | 10140 |
|
|
2025
Q2 | – | Sell |
-426
| Closed | -$3.3K | – | 9993 |
|
|
2025
Q1 | $3.3K | Sell |
426
-360
| -46% | -$4.32K | ﹤0.01% | 9248 |
|
|
2024
Q4 | $10.4K | Sell |
786
-1,551
| -66% | -$14.4K | ﹤0.01% | 9180 |
|
|
2024
Q3 | $23.3K | Sell |
2,337
-15,661
| -87% | -$236K | ﹤0.01% | 9281 |
|
|
2024
Q2 | $401K | Buy |
17,998
+1,443
| +9% | +$44.6K | ﹤0.01% | 7360 |
|
|
2024
Q1 | $973K | Buy |
16,555
+1,504
| +10% | +$64.8K | ﹤0.01% | 5475 |
|
|
2023
Q4 | $333K | Sell |
15,051
-20,409
| -58% | -$308K | ﹤0.01% | 7455 |
|
|
2023
Q3 | $765K | Sell |
35,460
-49,067
| -58% | -$1.93M | ﹤0.01% | 5574 |
|
|
2023
Q2 | $5.71M | Buy |
84,527
+66,366
| +365% | +$27.4M | ﹤0.01% | 2552 |
|
|
2023
Q1 | $8.47M | Buy |
18,161
+357
| +2% | +$189K | ﹤0.01% | 1808 |
|
|
2022
Q4 | $7.13M | Buy |
17,804
+2,170
| +14% | +$831K | ﹤0.01% | 2021 |
|
|
2022
Q3 | $5.08M | Sell |
15,634
-959
| -6% | -$309K | ﹤0.01% | 2589 |
|
|
2022
Q2 | $4.38M | Buy |
+16,593
| New | +$4.24M | ﹤0.01% | 2868 |
|
|
2022
Q1 | – | Sell |
-2,947
| Closed | -$1.03M | – | 10492 |
|
|
2021
Q4 | $1.04M | Buy |
2,947
+908
| +45% | +$283K | ﹤0.01% | 5823 |
|
|
2021
Q3 | $521K | Sell |
2,039
-3,911
| -66% | -$1.39M | ﹤0.01% | 7206 |
|
|
2021
Q2 | $3.96M | Buy |
5,950
+5,199
| +692% | +$3M | ﹤0.01% | 3051 |
|
|
2021
Q1 | $651K | Sell |
751
-1,079
| -59% | -$1.15M | ﹤0.01% | 6303 |
|
|
2020
Q4 | $1.7M | Buy |
1,830
+361
| +25% | +$379K | ﹤0.01% | 3782 |
|
|
2020
Q3 | $1.51M | Sell |
1,469
-45
| -3% | -$48.4K | ﹤0.01% | 3443 |
|
|
2020
Q2 | $1.53M | Buy |
1,514
+1,282
| +553% | +$1.19M | ﹤0.01% | 3434 |
|
|
2020
Q1 | $201K | Sell |
232
-2,416
| -91% | -$2.4M | ﹤0.01% | 4645 |
|
|
2019
Q4 | $2.84M | Buy |
2,648
+2,040
| +336% | +$2.08M | ﹤0.01% | 1557 |
|
|
2019
Q3 | $562K | Sell |
608
-101
| -14% | -$111K | ﹤0.01% | 3388 |
|
|
2019
Q2 | $801K | Buy |
+709
| New | +$776K | ﹤0.01% | 2987 |
|
|
2018
Q4 | – | Sell |
-975
| Closed | -$1.48M | – | 5160 |
|
|
2018
Q3 | $1.48M | Buy |
+975
| New | +$1.5M | ﹤0.01% | 2253 |
|
|
2018
Q1 | – | Sell |
-231
| Closed | -$304K | – | 4955 |
|
|
2017
Q4 | $273K | Sell |
231
-474
| -67% | -$594K | ﹤0.01% | 3871 |
|
|
2017
Q3 | $948K | Buy |
705
+357
| +103% | +$376K | ﹤0.01% | 2350 |
|
|
2017
Q2 | $281K | Buy |
+348
| New | +$242K | ﹤0.01% | 3667 |
|
|
2016
Q2 | – | Sell |
-532
| Closed | -$283K | – | 4210 |
|
|
2016
Q1 | $283K | Buy |
532
+166
| +45% | +$82.7K | ﹤0.01% | 3281 |
|
|
2015
Q4 | $279K | Buy |
+366
| New | +$243K | ﹤0.01% | 3188 |
|
|
2015
Q3 | – | Sell |
-482
| Closed | -$283K | – | 3746 |
|
|
2015
Q2 | $283K | Buy |
+482
| New | +$280K | ﹤0.01% | 2882 |
|
Other funds holding KYNB
AC
BC
Jane Street's KYNB Position: Q2 2026 in Review
Jane Street sold out of Kyntra Bio (KYNB) in Q2 2026, closing a stake of 12,228 shares — an estimated $82.9K sold.
Jane Street first reported a position in KYNB in Q2 2015 and held it in 32 quarters. The position peaked at $8.47M in Q1 2023. 27 funds tracked by Wall St. Rank hold KYNB as of Q2 2026.
- Jane Street reported no remaining Kyntra Bio position as of Q2 2026 after selling out during the quarter.
- Jane Street sold 12,228 Kyntra Bio shares in Q2 2026, an estimated $82.9K.
- Jane Street first reported a position in Kyntra Bio in Q2 2015 and held it in 32 quarters.
- Jane Street's Kyntra Bio position peaked at $8.47M in Q1 2023.
- 27 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.